Winclove Probiotics reveals details of a new platform designed to fast-track the probiotic product development cycle, which they say will generate €8m in turnover in the first five years of commercialisation.
Winclove Probiotics are to work with SkinBioTherapeutics in the design and development of a probiotic blend that addresses the symptoms associated with the skin condition, psoriasis.